bupropion has been researched along with Nervous System Diseases in 3 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to assess the analgesic potential of sustained-release (SR) bupropion for neuropathic pain." | 9.09 | Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. ( Davis, B; Semenchuk, MR, 2000) |
| "To ensure safer use of bupropion, health professionals must respect the strict contraindications and warnings about use of this drug in patients with a history of seizures." | 7.74 | Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. ( Beyens, MN; Guy, C; Laporte, S; Mounier, G; Ollagnier, M, 2008) |
| "The purpose of this study was to assess the analgesic potential of sustained-release (SR) bupropion for neuropathic pain." | 5.09 | Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. ( Davis, B; Semenchuk, MR, 2000) |
| "To ensure safer use of bupropion, health professionals must respect the strict contraindications and warnings about use of this drug in patients with a history of seizures." | 3.74 | Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. ( Beyens, MN; Guy, C; Laporte, S; Mounier, G; Ollagnier, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beerepoot, P | 1 |
| Lam, VM | 1 |
| Salahpour, A | 1 |
| Beyens, MN | 1 |
| Guy, C | 1 |
| Mounier, G | 1 |
| Laporte, S | 1 |
| Ollagnier, M | 1 |
| Semenchuk, MR | 1 |
| Davis, B | 1 |
1 trial available for bupropion and Nervous System Diseases
| Article | Year |
|---|---|
Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action | 2000 |
2 other studies available for bupropion and Nervous System Diseases
| Article | Year |
|---|---|
Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Topics: Amino Acid Substitution; Bupropion; Dopamine Plasma Membrane Transport Proteins; HEK293 Cells; Human | 2016 |
Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.
Topics: Adolescent; Adult; Aged; Angioedema; Antidepressive Agents, Second-Generation; Bupropion; Cerebrovas | 2008 |